Fernanda Leandra
Metabolomic profiling has emerged as a powerful tool in understanding the molecular intricacies of various diseases, including Endometrial Cancer (EC) and hyperplasia. This article explores recent advancements in metabolomic profiling of blood plasma in females with hyperplasia and EC, highlighting the potential of metabolomics in early detection, prognosis and personalized treatment strategies for these conditions.
Compartilhe este artigo
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Hindi 